U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H8O3S
Molecular Weight 184.212
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-STYRENESULFONIC ACID

SMILES

OS(=O)(=O)C1=CC=CC=C1C=C

InChI

InChIKey=VMSBGXAJJLPWKV-UHFFFAOYSA-N
InChI=1S/C8H8O3S/c1-2-7-5-3-4-6-8(7)12(9,10)11/h2-6H,1H2,(H,9,10,11)

HIDE SMILES / InChI

Molecular Formula C8H8O3S
Molecular Weight 184.212
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings.
2001 May
[Colonic necrosis caused by sodium polystyrene (kayexalate) in hemodialysis: myth or reality? Two case reports].
2002
[Colonic ulcer after prolongated administration of Kayexalate (sodium polystyrene sulfonate)].
2004 Mar
Hypernatraemia induced by sodium polystyrene sulphonate (Kayexalate) in two extremely low birth weight newborns.
2004 Mar
Sodium polystyrene sulfonate used to reduce the potassium content of a high-protein enteral formula: a quantitative analysis.
2004 Mar-Apr
Phytobezoar: an unusual cause of intestinal obstruction.
2005 Jul
Hyperkalemia after acute metabolic decompensation in two children with vitamin B12-unresponsive methylmalonic acidemia and normal renal function.
2006 Jul
Necrotizing enterocolitis in a 850 gram infant receiving sorbitol-free sodium polystyrene sulfonate (Kayexalate): clinical and histopathologic findings.
2007 Apr
Kayexalate Intake (in Sorbitol) and Jejunal Diverticulitis, a Causative Role or an Innocent Bystander?
2007 Dec 4
Functionalized polymer colloids bearing primary amino groups.
2007 Jul 15
Successful treatment of a colonic ulcer penetrating the urinary bladder caused by the administration of calcium polystyrene sulfonate and sorbitol.
2007 Oct
Positive intraluminal bowel contrast on computed tomography following oral ingestion of kayexelate.
2008 Dec
Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants.
2008 Mar
Chronic diseases and natural hazards: impact of disasters on diabetic, renal, and cardiac patients.
2008 Mar-Apr
Colonic mucosal necrosis following administration of calcium polystryrene sulfonate (Kalimate) in a uremic patient.
2009 Dec
Small intestinal obstruction due to phytobezoar: a case report.
2009 Dec 2
Refractory cardiopulmonary failure after glyphosate surfactant intoxication: a case report.
2009 Jan 30
Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol.
2009 May
Wenckebach Block due to Hyperkalemia: A Case Report.
2010
Methadone-induced delayed posthypoxic encephalopathy: clinical, radiological, and pathological findings.
2010
Gastric mucosal changes caused by Lugol's iodine solution spray: endoscopic features of 64 cases on screening esophagogastroduodenoscopy.
2010
[Mesenteric ischemia following a left radical nephrectomy].
2010 Jul
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 18:29:36 GMT 2023
Edited
by admin
on Sat Dec 16 18:29:36 GMT 2023
Record UNII
NR134FJ5E3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-STYRENESULFONIC ACID
Systematic Name English
BENZENESULFONIC ACID, 2-ETHENYL-
Systematic Name English
Code System Code Type Description
CAS
90111-29-8
Created by admin on Sat Dec 16 18:29:36 GMT 2023 , Edited by admin on Sat Dec 16 18:29:36 GMT 2023
PRIMARY
FDA UNII
NR134FJ5E3
Created by admin on Sat Dec 16 18:29:36 GMT 2023 , Edited by admin on Sat Dec 16 18:29:36 GMT 2023
PRIMARY
PUBCHEM
168625
Created by admin on Sat Dec 16 18:29:36 GMT 2023 , Edited by admin on Sat Dec 16 18:29:36 GMT 2023
PRIMARY